LRRC4C and neoplasm: PDAC cells was abolished in NGL-1KD PDAC cells treated with the same sEVs (Supplementary Fig. S4C), demonstrating that an NGL-1 deficiency in PDAC cells prevents the tumor-supportive benefit imparted by NetG1+ CAF-generated sEVs.